Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Lundbeck

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$42M
Portfolio companies 3
Rounds per year 0.14
Lead investments 1
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Biopharma
  • Therapeutics
  • Medical
  • Health Care
Summary

Lundbeck is the famous Corporate Investor, which was founded in 2000.

Among the most popular portfolio startups of the fund, we may highlight benevolent.ai, Proximagen, Naurex. Among the most popular fund investment industries, there are Medical Device, Biopharma. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups.

The top amount of exits for fund were in 2015. Opposing the other organizations, this Lundbeck works on 4 percentage points more the average amount of lead investments. The typical startup value when the investment from Lundbeck is more than 1 billion dollars. The fund is generally included in less than 2 deals every year. The real fund results show that this Corporate Investor is 13 percentage points more often commits exit comparing to other companies. The high activity for fund was in 2011. The common things for fund are deals in the range of 10 - 50 millions dollars.

The typical case for the fund is to invest in rounds with 3 participants. Despite the Lundbeck, startups are often financed by PathoCapital, Latterell Venture Partners, Genesys Capital. The meaningful sponsors for the fund in investment in the same round are Woodford Investment Management, Upsher Smith Laboratories, Takeda Pharmaceutical. In the next rounds fund is usually obtained by Woodford Investment Management, Takeda Ventures, Savitr Capital.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Lundbeck:
Typical Co-investors
Lundbeck is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Lundbeck:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Cooperathon Canada, Montreal, Quebec
Decibel Partners California, Palo Alto, United States
Fenghai Capital -
GSM Fund -
Hampstead Park Capital -
Meyer Keith -
Qlue Indonesia, Jakarta, Jakarta Raya
Scotiabank Canada, Ontario, Toronto
Sham France, Lyon, Rhone-Alpes
Wichita Technology Corporation (WTC) Kansas, United States, Wichita

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Naurex

Biopharma
Biotechnology
Therapeutics
$25M06 May 2014 Illinois, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Lundbeck?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 42M
Rounds per year 0.14
Peak activity year 2014
Lead investments 1
Exits 1
Group Appearance index 0.67

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Naurex

Biopharma
Biotechnology
Therapeutics
$25M06 May 2014 Illinois, United States
Crunchbase icon

Content report

The following text will be sent to our editors: